| Income Statement |
| Total Revenue | 161.00 |
|
| Revenues (USD) | 161.00 |
| Cost of Revenue | 763.00 |
| Gross Profit | -602.00 |
| Operating Expenses | 2.28M |
| Research and Development Expense | 1.69M |
| Selling, General and Administrative Expense | 593.18K |
| Operating Income | -2.28M |
| Interest Expense | 176.88K |
| Net Income | -2.46M |
| Net Income Common Stock | -2.46M |
| Net Income Common Stock (USD) | -2.46M |
| Consolidated Income | -2.46M |
| Earnings per Basic Share | -0.41 |
| Earnings per Basic Share (USD) | -0.41 |
| Earnings per Diluted Share | -0.41 |
| Earning Before Interest & Taxes (EBIT) | -2.28M |
| Earning Before Interest & Taxes (USD) | -2.28M |
| Weighted Average Shares | 6.03M |
| Weighted Average Shares Diluted | 6.03M |
| Balance Sheet |
| Cash and Equivalents | 2.84M |
| Cash and Equivalents (USD) | 2.84M |
| Trade and Non-Trade Receivables | 23.00 |
| Current Assets | 3.52M |
| Property, Plant & Equipment Net | 290.08K |
| Total Assets | 22.08M |
| Debt Current | 4.81M |
| Total Debt | 13.81M |
| Current Liabilities | 6.35M |
| Debt Non-Current | 9.00M |
| Total Liabilities | 16.39M |
| Accumulated Retained Earnings (Deficit) | -69.98M |
| Accumulated Other Comprehensive Income | -261.73K |
| Shareholders Equity | 5.69M |
| Shareholders Equity (USD) | 5.69M |
| Assets Non-Current | 18.56M |
| Total Debt (USD) | 13.81M |
| Deferred Revenue | 350.00K |
| Goodwill and Intangible Assets | 18.11M |
| Inventory | 315.64K |
| Liabilities Non-Current | 10.04M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.17M |
| Net Cash Flow from Financing | 3.41M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.42M |
| Capital Expenditure | -6.79K |
| Issuance (Purchase) of Equity Shares | 601.60K |
| Issuance (Repayment) of Debt Securities | 2.81M |
| Net Cash Flow from Investing | -79.00 |
| Net Cash Flow from Operations | -983.42K |
| Effect of Exchange Rate Changes on Cash | -6.97K |